Skip to main content
Premium Trial:

Request an Annual Quote

Just Like that Ant and His Rubber Tree Plant, We've Got High Hopes

Today's a big day for your genes. As this New York Times article reports, the US senator blocking the Genetic Information Nondiscrimination Act bill has been mollified, and the bill is expected to be up for debate and a vote sometime today. The story quotes Edward Abrahams from the Personalized Medicine Coalition as saying, "This bill removes a significant obstacle to the advancement of personalized medicine." President Bush has said he would sign the bill into law if it's passed by Congress.

For more on GINA, check out Blaine Bettinger's blog post about its history and coverage in the media. If all goes well for the bill, there could be much to celebrate on DNA Day tomorrow.

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.